Praxis Precision Medicines, Inc.
PRAX
$48.09
-$0.69-1.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.77M | 8.12M | 8.55M | 1.61M | 1.77M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.77M | 8.12M | 8.55M | 1.61M | 1.77M |
| Cost of Revenue | 221.98M | 186.24M | 152.41M | 114.51M | 89.89M |
| Gross Profit | -214.22M | -178.11M | -143.86M | -112.91M | -88.12M |
| SG&A Expenses | 57.37M | 54.89M | 56.31M | 51.11M | 44.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 279.35M | 241.13M | 208.72M | 165.62M | 134.47M |
| Operating Income | -271.59M | -233.01M | -200.17M | -164.02M | -132.70M |
| Income Before Tax | -251.01M | -212.56M | -182.82M | -151.02M | -123.74M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -251.01 | -212.56 | -182.82 | -151.02 | -123.74 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -251.01M | -212.56M | -182.82M | -151.02M | -123.74M |
| EBIT | -271.59M | -233.01M | -200.17M | -164.02M | -132.70M |
| EBITDA | -271.35M | -232.71M | -199.81M | -163.59M | -132.26M |
| EPS Basic | -12.29 | -10.71 | -10.27 | -10.30 | -10.27 |
| Normalized Basic EPS | -7.76 | -6.78 | -6.46 | -6.44 | -6.42 |
| EPS Diluted | -12.29 | -10.71 | -10.27 | -10.30 | -10.27 |
| Normalized Diluted EPS | -7.76 | -6.78 | -6.46 | -6.44 | -6.42 |
| Average Basic Shares Outstanding | 81.40M | 78.75M | 71.59M | 60.67M | 50.83M |
| Average Diluted Shares Outstanding | 81.40M | 78.75M | 71.59M | 60.67M | 50.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |